Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMYTCVE:BMKCVE:ICCCVE:NXS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMYTAmryt Pharma$14.70+0.1%$14.64$6.41▼$14.77$940.21M0.84757,360 shs2.39 million shsBMKMacDonald Mines ExplorationC$0.09-10.5%C$0.08C$0.03▼C$0.10C$3.24M0.1567,505 shs26,780 shsICCICC LabsC$1.62-5.8%C$1.62C$0.87▼C$2.00C$223.64MN/A799,310 shs646,156 shsNXSNexus GoldC$0.02C$0.01C$0.01▼C$0.02C$682K0.7378,757 shs3,266 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMYTAmryt Pharma0.00%0.00%0.00%0.00%0.00%BMKMacDonald Mines Exploration0.00%0.00%0.00%0.00%+112.50%ICCICC Labs0.00%0.00%0.00%0.00%0.00%NXSNexus Gold0.00%+50.00%+50.00%+50.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMYTAmryt PharmaN/AN/AN/AN/AN/AN/AN/AN/ABMKMacDonald Mines ExplorationN/AN/AN/AN/AN/AN/AN/AN/AICCICC LabsN/AN/AN/AN/AN/AN/AN/AN/ANXSNexus GoldN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMYTAmryt Pharma 0.00N/AN/AN/ABMKMacDonald Mines Exploration 0.00N/AN/AN/AICCICC Labs 0.00N/AN/AN/ANXSNexus Gold 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMYTAmryt Pharma$222.54M4.22$0.98 per share14.98$5.58 per share2.63BMKMacDonald Mines Exploration-C$74K-43.74C$0.01 per share13.00C($0.02) per share-4.25ICCICC LabsC$533.68K419.04C$0.06 per share28.42C$0.29 per share5.68NXSNexus GoldN/AN/AC$0.00 per share10.00C($0.01) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMYTAmryt Pharma$1M-$0.06N/A735.00N/A-8.19%1.70%0.75%N/ABMKMacDonald Mines Exploration-C$1.28MN/AN/A∞N/AN/A-1,679.48%-118.05%N/AICCICC LabsN/AC$0.0295.29∞N/AN/AN/AN/AN/ANXSNexus Gold-C$1.03M-C$0.02N/A∞N/AN/A-1,307.50%-18.27%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMYTAmryt PharmaN/AN/AN/AN/AN/ABMKMacDonald Mines ExplorationN/A1.24%N/AN/AN/AICCICC LabsN/AN/AN/AN/AN/ANXSNexus GoldN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMYTAmryt Pharma0.641.570.94BMKMacDonald Mines Exploration3.840.100.27ICCICC LabsN/A24.848.74NXSNexus Gold14,120.330.030.38Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMYTAmryt Pharma71.31%BMKMacDonald Mines ExplorationN/AICCICC LabsN/ANXSNexus GoldN/AInsider OwnershipCompanyInsider OwnershipAMYTAmryt Pharma5.66%BMKMacDonald Mines Exploration6.86%ICCICC LabsN/ANXSNexus Gold0.48%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMYTAmryt Pharma2,02063.96 million60.34 millionNot OptionableBMKMacDonald Mines Exploration238.08 millionN/ANot OptionableICCICC LabsN/A138.05 millionN/ANot OptionableNXSNexus GoldN/A45.47 millionN/ANot OptionableNXS, BMK, ICC, and AMYT HeadlinesRecent News About These CompaniesNexus Gold (CVE:NXS) Trading Up 50% - Here's WhyJuly 6 at 3:53 AM | americanbankingnews.comNexus Gold (CVE:NXS) Trading Up 50% - Here's What HappenedJuly 6 at 3:15 AM | americanbankingnews.comNexus Gold (CVE:NXS) Trading 50% Higher - What's Next?July 6 at 2:22 AM | americanbankingnews.comNexus Gold (CVE:NXS) Trading 50% Higher - Here's WhyJuly 6 at 2:49 AM | americanbankingnews.comNexus to Solana (NXS to SOL)April 7, 2025 | markets.businessinsider.comNexus to Litecoin (NXS to LTC)March 18, 2025 | markets.businessinsider.comNexus Gold Launches Private Placement and Appoints New Interim CFOMarch 14, 2025 | tipranks.comBitcoin to Nexus (BTC to NXS)February 18, 2025 | markets.businessinsider.comNexus Minerals Unveils Promising Gold DiscoveriesNovember 10, 2024 | msn.comNexus Minerals Schedules Annual General Meeting for 2024October 25, 2024 | markets.businessinsider.comNexus Minerals Announces Annual General Meeting DetailsOctober 25, 2024 | markets.businessinsider.comGold Nexus Pro Review: Is It Worth the Price?October 24, 2024 | msn.comRecord gold price sees Nexus dust off Pinnacles JV studyOctober 16, 2024 | miningweekly.comProtocol Village: Nexus, Developer of Zero-Knowledge Virtual Machine, Launches 'World's First Open Prover Network' in BetaOctober 10, 2024 | msn.comBakersfield College's Renegade Nexus pantry gets gold certificationOctober 1, 2024 | msn.comNexus raises cash for Wallbrook projectSeptember 7, 2024 | miningweekly.comKen Carson Builds Nexus Brand with Soul Food and Craft Beer in New MexicoAugust 31, 2024 | msn.comNexus Industrial REIT: More Upside For 8% YielderAugust 18, 2024 | seekingalpha.comNext Science Limited (ASX: NXS) - Share Price and ResearchApril 28, 2024 | intelligentinvestor.com.auINexus Gold Announces Private PlacementApril 12, 2024 | goldseiten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNXS, BMK, ICC, and AMYT Company DescriptionsAmryt Pharma NASDAQ:AMYTAmryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.MacDonald Mines Exploration CVE:BMKC$0.08 -0.01 (-10.53%) As of 05/6/2025MacDonald Mines Exploration Ltd. engages in the acquisition, exploration, and development of mineral properties in Canada. The company primarily explores for gold, silver, copper, cobalt, and nickel deposits. It owns 100% interests in the Scadding-Powerline-Jovan project that covers an area of 19,455 hectares located in the southeast of the prolific Sudbury Mining Camp in Northern Ontario; and the Hembruff Copper Property, which consists of 30 mining claims that covers an area of 6.64 square kilometers situated in the Elliot Lake, Ontario. The company was formerly known as MacDonald Mines Limited. MacDonald Mines Exploration Ltd. was founded in 1935 and is based in Toronto, Canada.ICC Labs CVE:ICCC$1.62 -0.10 (-5.81%) As of 11/26/2018ICC Labs Inc., through its subsidiaries, produces and sells cannabis in Uruguay. It offers recreational cannabis, medicinal cannabis, cannabinoid extracts, and by-products for medicinal, recreational, and industrial use, as well as industrial hemp. The company is headquartered in Vancouver, Canada.Nexus Gold CVE:NXSC$0.02 0.00 (0.00%) As of 07/7/2025 09:30 AM EasternNexus Gold Corp. engages in the exploration and evaluation of mineral properties in West Africa. The company explores for gold deposits. It holds a 100% interest in Dakuli II Property which covers an area of 9,800 hectares located in the Burkina Faso, West Africa. The company also has an option to acquire 90% interests in the Fofora Gold Property covering approximately an area of 6,200 hectares located in the Burkina Faso, West Africa. Nexus Gold Corp. is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Believe the Hype? Can SoFi Maintain Its 3-Month Rally? Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play Why Centene Stock Dropped 40% — And Whether It's a Buy Now D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
